Ridley Q&A

Foley & Lardner LLP partners Monica Chmielewski and Kyle Faget shared insights on the growing adoption of artificial intelligence in clinical trials in the Clinical Trials Arena article, "Are regulators keeping pace with AI adoption in clinical trials?"

Texas Governor Greg Abbott signed Senate Bill 29 into law, a major legislative development aimed at enhancing the state’s corporate governance environment and positioning Texas as a leading destination for incorporation. Foley partners Christopher Babcock and Christopher Converse were quoted in Texas Lawyer’s article, “New Texas Law 'Eliminates Rogue Shareholders,' Abbott Says,” discussing the impact of the legislation and how it strengthens Texas’s appeal as a business-friendly jurisdiction.

In today's data-driven sports industry, teams, leagues and sponsors increasingly rely on biometric and performance data to enhance player performance, prevent injuries and optimize contract negotiations. Such data collection often includes highly sensitive physiological and health information that goes beyond mere statistics, prompting additional ethical and legal considerations.